ZEB2 and acute myeloid leukemia: The ability of EMT transcription factors to alter LSD1 function is an emerging theme in AML and other leukemias such as ETP-ALL, as ZEB2 has previously been demonstrated to interact with LSD1 [139,166] in both of these settings.